Botanical species · safety record

Crateva nurvala

The EFSA Compendium of Botanicals holds 3 constituent measurements and 1 adverse-effect record for Crateva nurvala. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Crateva nurvala Buch.-Ham.

3Constituent measurements

1Safety records

3Cited sources

0Licensed products (Canada)

Also recorded as

Crateva lophosperma Kurz

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Bark	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Melatonin	Bark	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Steroidal glycosides	Bark	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Reproductive	Uterus	Bark	Solvent extraction	Rat (as animal)	Reproduction toxicity	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Sharma, B.B., Varshney, M.D., Gupta, D.N., Prakash, A.O. Antifertility screening of plants. Part I. Effect of ten indigenous plants on early pregnancy in albino rats. Pharmaceutical biology, 1983, vol. 21, no. 4, p. 183-187. DOI
Sinha, Sadhna., Mishra, Priyanka., Amin, Hina., Rah, Bilal., Nayak, Debasis., Goswami, Anindya., Kumar, Naresh., Vishwakarma, Ram., Ghosal, Sabari. A new cytotoxic quinolone alkaloid and a pentacyclic steroidal glycoside from the stem bark of Crataeva nurvala: Study of anti-proliferative and apoptosis inducing property. European journal of medicinal chemistry, 2013, vol. 60, p. 490-496.
Bhattacharjee, Atanu., Shashidhara, Shastry Chakrakodi., Saha, Santanu. Isolation, purification and structural elucidation of N-acetyl-5-methoxytryptamine (Melatonin) from Crataeva nurvala Buch-Ham stem bark. American journal of phytomedicine and clinical therapeutics, 2014, vol. 2, no. 3), 301-30, p. 9.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature